Institute for Follicular Lymphoma Innovation
ActivePhilanthropy & VoluntarismMakes PRIs
About Institute for Follicular Lymphoma Innovation
The Institute for Follicular Lymphoma Innovation is a highly focused biomedical research funder that directs almost all of its dollars to translational and clinical research aimed at finding a cure for follicular lymphoma. It funds a mix of specialized disease organizations, academic medical centers, and international research institutes, typically supporting named research programs or projects rather than general operating expenses. Grants are substantial and targeted, often made repeatedly to the same investigators or institutions to advance long‑term research agendas.
Focus Areas
Follicular lymphoma-focused biomedical research and clinical trialsSupport for lymphoma research consortia and specialized advocacy/research nonprofits (e.g., Lymphoma Research Foundation, LYSARC)Funding for academic medical centers and cancer institutes with follicular lymphoma programs (e.g., Washington University, Mayo Clinic, City of Hope)International translational research partnerships (e.g., The Francis Crick Institute, INSERM)
Who They Fund
patients with follicular lymphomahematologic cancer researchers and clinician‑scientists
About Institute for Follicular Lymphoma Innovation
The Institute for Follicular Lymphoma Innovation concentrates its grantmaking on a single disease area: follicular lymphoma. Across recent awards, it backs translational and clinical research, specialized research nonprofits, and academic medical centers working toward improved treatments and a cure. The largest recent grant listed is $3,282,650 to the Lymphoma Research Foundation in New York for research towards finding a cure for follicular lymphoma, followed by $2,336,450 to Lysarc in Pierre-Benite for the same purpose. That disease-specific focus runs through the rest of the portfolio. The foundation has supported The Leukemia & Lymphoma Society Inc in Rye Brook, New York, Washington University in St. Louis, and City of Hope in Duarte, California, all with grants framed around follicular lymphoma research. It also funds international research institutions, including The Francis Crick Institute in London and Inserm in Paris, showing a pattern that extends beyond one country while staying tightly centered on one hematologic cancer. Its recent grant history suggests a mix of large research awards and repeated support for collaborators already engaged in follicular lymphoma work. The grants are usually directed to named projects or programs rather than broad unrestricted support.
What Institute for Follicular Lymphoma Innovation Funds
The clearest theme in the recent grants is disease-focused research infrastructure. The Institute for Follicular Lymphoma Innovation gave $1,211,957 to The Leukemia & Lymphoma Society Inc in Rye Brook, New York, and $223,667 to Cure (llsflfifli), also in Rye Brook, both for research towards finding a cure for follicular lymphoma. It also supports academic medical centers with established lymphoma programs. Washington University in St. Louis received $700,960 in 2025 for follicular lymphoma research, while UCLA in Los Angeles received $275,000 in 2025 for the same purpose. Internationally, the foundation funds biomedical research institutions outside the United States. The Francis Crick Institute Limited in London received $249,969 in 2025, and Inserm in Paris received $239,133 in 2025, each with the same follicular lymphoma research purpose. The recent record also includes LYSARC in Pierre Benite, which received $514,538 in 2023, showing continuity with specialized lymphoma research organizations.
How Institute for Follicular Lymphoma Innovation Gives
Financial Snapshot
Annual Giving
$4.6M
Total Assets
$26.6M
Total Revenue
$20.7M
Total Expenses
$8.2M
Typical Grant Size
Most grants fall between $264K and $275K, with a median of $275K.
25th Percentile
$264K
Median
$275K
75th Percentile
$275K
Geographic Reach
Regional4 states funded
About 0% of grants go to recipients in NY.
Funding intensity
LowHigh
Headquarters
Funding intensity
LowHigh
Where Institute for Follicular Lymphoma Innovation Funds
Top 4 recipient countries by grant volume for Institute for Follicular Lymphoma Innovation.
| Rank | Country | Grants | Total | Share |
|---|---|---|---|---|
| 1 | United StatesDomestic | 13 | $22.2M | 59.1% |
| 2 | France | 6 | $12.9M |
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Institute for Follicular Lymphoma Innovation?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime